ARCHIVES

Study Finds No Benefit for Frequent CA125 Testing in Recurrent Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 22 | June 5, 2009

Download PDF Visit The Full Archive

Related Articles

Bills Would Give FDA Authority to Approve Generic Biotech Drugs.

February 16, 2007

NCAB Disproves W. Virginia Construction Grant, Okays Funding Three New, Three Carryover Awards

May 24, 1985

Construction Money In Budget Earmarked For Frederick

February 9, 1990

Cancer Center Lineup complete: 11 Renewals, Funding Continued for Three, Two Unfunded

September 28, 1990

Anna Barker Named Deputy Director for Strategic Scientific Initiatives

December 6, 2002

Centers Network Release “Version 1.0” Of Clinical Guidelines for Eight Cancers

March 15, 1996